基于密码子使用模式的冠状病毒亲缘关系分析

重症急性呼吸综合症(severe acute respiratorysyndrome,SARS),临床表现为非典型肺炎.由于SARS具有很高的传染性和一种新型的冠状病毒(SARS-CoV)被认为是引起SARS的病原体.SARS冠状病毒(SARS-CoV)属于巢状病毒目(OrderN idovirales),冠状病毒科(Fam ily Coronaviri-dae),冠状病     

SARS冠状病毒的诊断性实验研究

严重急性呼吸综合征(SARS)是一种新的人类感染性疾病，其致病菌为SARS冠状病毒(SARS-CoV)。本文就SARS-CoV发现过程、病毒特点及检测方法的研究进展和应用情况加以概述。     

冠状病毒感染过程中血管紧张素转换酶2作用的研究进展

冠状病毒可引起人类呼吸道、肠道等多系统感染.严重急性呼吸综合征冠状病毒(SARS-CoV,2003年)、人冠状病毒NL63(HCoV-NL63,2004年)以及目前的新型冠状病毒(SARS-CoV-2,2019年)均已被证实通过与黏膜的血管紧张素转换酶2(ACE2)结合感染人体.因此研究冠状病毒感染过程中ACE2的作用有助于了解冠状病毒的致病机制,为新型冠状病毒肺炎的防治提供参考.该文综述了ACE2在3种冠状病毒感染人体过程中作用的研究进展,主要涉及病毒棘突蛋白识别ACE2胞外域顶端,且有跨膜蛋白酶丝氨酸2(TMPRSS2)等因子参与其中.针对冠状病毒与ACE2结合的机制,可以从多个靶点设计防治药物.     

SARS-CoV棘突蛋白片段在E.coli中的表达及免疫活性分析

SARS-冠状病毒(SARS-CoV)棘突蛋白(Spike,S)是构成病毒包膜突起的主要成分,属于型膜糖蛋白,全长1255aa,在病毒入侵宿主细胞中起重要作用.本文利用生物信息学技术,界定冠状病毒SARS-CoVS蛋白的抗原决定区域,通过PCR扩增相应片段,克隆至原核表达载体pET-H,得到四个重组质粒pET-HS1、pET-HS3、pET-HS4、pET-HS5.经序列测定证实后,转化大肠杆菌BL21(DE3),IPTG诱导获得表达,产物经紫外薄层扫描显示目的蛋白占菌体细胞总蛋白量的20%~30%.经Westernblot检测,表达蛋白与恢复期SARS病人血清呈高反应原性.纯化相应蛋白免疫小鼠,所获抗血清效价达1∶3×103.与SARS诊断试剂反应呈阳性,这一工作将为进一步研究S蛋白的定位、功能及SARS诊断提供帮助.     

基于虚拟筛选方法从中药中发现SARS-CoV-2抑制剂

主蛋白酶(Mpro)在SARS-CoV-2病毒自我复制过程中发挥重要作用,以蛋白酶Mpro为靶标的药物可以有效地治疗SARS-CoV-2病毒感染.因此,本研究对中药数据库TCMD进行虚拟筛选,筛选得到的化合物满足Lipinski规则与Veber规则,且通过TOPKAT预测,筛选得到的化合物具有良好的成药性.研究分子对接下的互作模式以及通过自由结合能验证复合物体系的稳定性.结果显示,化合物1(ZINC33830770,灵芝属三萜类化合物)和化合物4(ZINC1335889,杭菊中的不饱和脂肪酸异丁基酰胺)与阳性对照药物Talampicillin类似,在蛋白酶Mpro的活性口袋中,均表现出较强的亲和力以及稳定性.因此化合物1和化合物4可以通过抑制蛋白酶Mpro对COVID-19发挥潜在的防治作用.     

引起人非典型性肺炎的冠状病毒基因组与其它冠状病毒基因组的初步比较

一种在世界范围内突然爆发的致命流行病——急性呼吸窘迫综合症(SARS)击倒了数干人，一种全新的冠状病毒被认为是其病原．5个SARS相关冠状病毒的全基因组序列已经完成．我们进行了SARS相关冠状病毒和其它冠状病毒的基因组进化分析和序列比较，结果显示：1．SARS相关冠状病毒不直接来自于任何已知的冠状病毒；2．E蛋白的基因可能是在近期从其它病毒横向转移到SARS病毒中来的；3．Sl和S2基因发生了较大范围的缺失或插入突变．这些基因横向转移和突变改变了SARS相关病毒的表面结构和抗原性，极有可能是导致其获得侵染人类细胞的主要原因．     

新型冠状病毒

正新冠状病毒可分为α、β、γ、δ4个属,与人类疾病相关的冠状病毒均为α和β属冠状病毒。已知可造成人类疾病的冠状病毒有:普通人类冠状病毒229E、NL63、OC43、HKU1,严重急性呼吸综合征冠状病、(severe acute respiratory syndrome coronavirus,SARS-CoV),中东呼吸综合征冠状病毒(Middle     

冠状病毒与眼部疾病的关系

 20世纪60年代，科学家首次分离出可感染人类的冠状病毒，HCoV-OC43和HCoV-229E早在1966年和1967年已被发现，但直到2003年SARS在全球爆发后冠状病毒才被广泛关注。综述了目前已发现的人感染冠状病毒特点及其与眼部的关系，以期在新型冠状病毒肆虐之际，为眼科一线临床医师筛查、确诊病例提供参考。     

MCTD、SS和RA患者血清中SARS-CoV抗体阳性原因分析

为探讨严重急性呼吸综合征(SARS)冠状病毒(SARS-CoV)抗体在SARS病原学诊断中的特异性及其在干燥综合征(SS)、混合结缔组织病(MCTD)和类风湿性关节炎(RA)患者血清中的假阳性问题，应用酶联免疫吸附试验(ELISA)和间接免疫荧光法(IFA)检测了111例正常对照和46例SS、MCTD和RA患者血清中SARS-CoV抗体的阳性率。结果在正常对照和SS、MCTD和RA患者中，应用ELISA测定SARS-CoV抗体的阳性率分别为3．6％(4／111)和19．6％(9／46)，经IFA检测，上述SARS-CoV抗体阳性者均为阴性。提示IFA诊断SARS的特异性为100％，ELISA诊断SARS存在一定的假阳性。     

SARS冠状病毒RNA聚合酶基因片段体外组装和siRNA干扰研究

为了安全便捷地获取严重急性呼吸系统综合征冠状病毒(Severe Acute Respiratory Syndrome coronavirus,SARS coronavirus)的RdRp基因,作者合成了26条寡聚核苷酸片段,利用组装PCR(assembly PCR)在体外构建了SARS病毒的RdRp基因片段,并建立了基于Vero E6细胞的SARS RdRp基因的稳定表达株.之后设计了4对针对SARS RdRp基因的siRNA,基因干扰表明这4对siRNA均能高效干扰SARS RdRp基因在Vero E6细胞中的表达.至此,本文提供了一种安全便捷地获取病毒基因的方法.     

SARS相关冠状病毒刺突糖蛋白的研究(综述)

概述了SARS—CoV的S蛋白的结构及功能相关研究。严重急性呼吸综合症相关的冠状病毒(SARS-CoV)引起2003年我国南方非典型肺炎爆发流行，波及多个国家和地区。目前全球许多学对SARS-CoV进行了广泛的研究，发现S蛋白是病毒表面的主要蛋白，它构成冠状病毒科特征性的冠状样结构，在严重急性呼吸综合症的发病机制起着关键性作用，可介导表达相关受体的宿主细胞感染。现已鉴定出SARS-CoV的S蛋白相关受体，同时它在抗病毒感染中是一个关键靶蛋白。     

Genome sequence variation analysis of two SARS coronavirus isolates after passage in Vero cell culture

SARS coronavirus is an RNA virus whose replication is error-prone, which provides possibility for escape of host defenses, and even leads to evolution of new viral strains during the passage or the transmission. Lots of variations have been detected among different SARS-CoV strains. And a study on these variations is helpful for development of efficient vaccine. Moreover, the test of nucleic acid characterization and genetic stability of SARS-CoV is important in the research of inactivated vaccine. The whole genome sequences of two SARS coronavirus strains after passage in Vero cell culture were determined and were compared with those of early passages, respectively. Results showed that both SAPS coronavirus strains have high genetic stability, although nearly 10 generations were passed. Four nucleotide variations were observed between the second passage and the llth passage of Sinol strain for identification of SARS inactivated vaccine. Moreover, only one nucleotide was different between the third passage and the 10th passage of Sino3 strain for SARS inactivated vaccine. Therefore, this study suggested it was possible to develop inactivated vaccine against SARS-CoV in the future.     

SARS的研究进展

2003年3月,发现SARS病原是一种从未在人类或动物中发现过的新的冠状病毒.其基因组结构与其他的冠状病毒相似,由29727核苷酸组成,有11个开放阅读框.通过多基因分析序列比较说明,SARS冠状病毒与已知的冠状病毒无关.针对SARS冠状病毒的各种特征及研究进展进行了综述.     

A Coordination Model of Gene Sequences for SARS-CoV and its Receptor

IntroductionFrom the emergence of SARS CoV, manystudies havebeen done on its biological medicine aspects, such aspathogeny characteristics, mechanisms of causing disease,clinic diagnosis and treatment, bacterin development andthe spreading rules. At the level of molecule biology,studies have been done on its genome sequences characteristics, structures and functions of the translatedproteins, and the evolution relationships in sequences[1 5].The caus…     

Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus

Spike (S) proteins of coronaviruses, including the coronavirus that causes severe acute respiratory syndrome (SARS), associate with cellular receptors to mediate infection of their target cells. Here we identify a metallopeptidase, angiotensin-converting enzyme 2 (ACE2), isolated from SARS coronavirus (SARS-CoV)-permissive Vero E6 cells, that efficiently binds the S1 domain of the SARS-CoV S protein. We found that a soluble form of ACE2, but not of the related enzyme ACE1, blocked association of the S1 domain with Vero E6 cells. 293T cells transfected with ACE2, but not those transfected with human immunodeficiency virus-1 receptors, formed multinucleated syncytia with cells expressing S protein. Furthermore, SARS-CoV replicated efficiently on ACE2-transfected but not mock-transfected 293T cells. Finally, anti-ACE2 but not anti-ACE1 antibody blocked viral replication on Vero E6 cells. Together our data indicate that ACE2 is a functional receptor for SARS-CoV.     

SARS-CoVS基因表达及纯化

严重急性呼吸道综合症是由一种新的冠状病毒SARS-CoY引起的．作者通过PCR扩增得到了S蛋白的6个编码片段，并利用表达载体pET28a( )在E．coli BL21中进行了原核表达．通过亲和层析纯化了包含大部分ACE2结合区域的S蛋白片段(S4)．ELISA分析结果表明S4与SARS病人恢复期血清具有良好的反应能力．     

Bioinformatical study on the proteomics and evolution of SARS-CoV

A novel coronavirus has been identified as the causative agent of the severe acute respiratory syndrome (SARS). For all the SARS-CoV associated proteins derivated from the SARS-CoV genome, the physiochemical properties such as the molecular weight, isoelectric point and extinction coefficient of each protein were calculated. The transmembrane segments and subeellular localization (SubLoeation) prediction and conserved protein motifs search against database were employed to analyze the function of SARS-CoV proteins. Also, the homology protein sequence alignment and evolutionary distance matrix calculation between SARS-CoV associated proteins and the corresponding proteins of other coronaviruses were employed to identify the classification and phylogenetic relationship between SARS-CoV and other coronaviruses. The results showed that SARS-CoV is a novel coronavirus which is different from any of the three previously known groups of coronviruses, but it is closer to BoCoV and MHV than to other coronaviruses. This study is in aid of experimental determination of SARS-CoV proteomics and the development of antiviral vaccine.     

Phylogeny of SARS-CoV as inferred from complete genome comparison

SARS-CoV, as the pathogeny of severe acute respi-ratory syndrome (SARS), seems to be the first coronavirus that is lethal to humans. Coronavirus (family Coronaviri-dae, genus Coronavirus) is an enveloped, single-stranded plus sense RNA virus whose genome has approximately 30 kb size. Whereas coronaviruses may cause severe dis-ease in animals, coronaviruses human strains only cause mild diseases until SARS-CoV was discovered. To date, SARS-CoV genomes from 12 isolates have been comp…     

Molecular phylogeny of coronaviruses including human SARS-CoV

The outbreak of SARS sets an urgent task to reveal the origin of human SARS-CoV, i.e. its relation to other known species of coronavirus, and to trace the genetic variation in the spreading process of SARS. Partial answer to the problem may be obtained from phylogenetic analy-sis of available genomes. We call a phylogenetic tree of different species of coronavirus including the human SARS-Cov a CoV Tree and that of different isolates of SARS-CoV a SARS Tree. CoV trees have been c…